| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | aspartate | 0.3562 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.3844 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.3978 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.3998 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.4294 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.4433 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.4773 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.4778 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.4813 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5022 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5052 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5117 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5166 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5415 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5466 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5541 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5631 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5811 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5829 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5830 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.5884 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6066 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6135 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6247 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6412 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6527 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6731 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6818 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.6867 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7000 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7081 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7083 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7161 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7164 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7196 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7212 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7234 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7238 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7247 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7403 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7411 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7424 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7443 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7486 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7519 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7546 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7556 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7573 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7660 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7677 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7749 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7851 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7874 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7906 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.7938 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8001 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8050 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8151 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8162 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8223 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8260 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8326 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8381 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8394 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8528 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8565 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8669 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8720 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8852 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8923 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8952 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.8990 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9047 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9059 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9149 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9190 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9203 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9209 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9268 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9268 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9272 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9325 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9342 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9422 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9454 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9519 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9620 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9662 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9688 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9810 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9832 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9854 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 0.9945 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0000 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0044 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0146 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0167 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0259 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0275 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0450 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0456 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0507 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0566 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0923 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0923 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0977 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.0998 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1171 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1192 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1235 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1365 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1366 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1445 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1471 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1495 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1548 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1785 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.1806 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2193 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2224 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2229 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2301 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2399 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2455 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2489 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2654 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2664 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2967 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.2970 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3051 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3146 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3169 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3248 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3325 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3490 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3564 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3648 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3762 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3860 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3883 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.3911 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.4067 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.4452 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.4540 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.4783 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.4986 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.5238 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.5430 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.5443 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 1.5549 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.5938 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.5990 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.6116 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.6121 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.6202 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.6876 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.7035 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.7983 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.8254 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.8606 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.8714 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9043 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9107 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9182 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9448 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9479 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9520 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9689 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 1.9849 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 2.0400 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 2.0592 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 2.0703 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 2.1320 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 2.2154 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 2.3169 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 2.3653 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 2.5028 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 2.5397 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | aspartate | 2.5604 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 2.6153 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 2.6250 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 2.6759 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | aspartate | 2.9037 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 2.9669 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 3.1074 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 3.2285 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | aspartate | 3.9754 | scaled units | Low-Dose | +4HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|